Mainz Biomed (MYNZ) Cash & Equivalents (2020 - 2025)
Historic Cash & Equivalents for Mainz Biomed (MYNZ) over the last 6 years, with Q2 2025 value amounting to $6.2 million.
- Mainz Biomed's Cash & Equivalents fell 1181.25% to $6.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.2 million, marking a year-over-year decrease of 1181.25%. This contributed to the annual value of $6.2 million for FY2024, which is 1181.25% down from last year.
- Per Mainz Biomed's latest filing, its Cash & Equivalents stood at $6.2 million for Q2 2025, which was down 1181.25% from $6.2 million recorded in Q4 2024.
- Mainz Biomed's 5-year Cash & Equivalents high stood at $26.0 million for Q2 2022, and its period low was $6.2 million during Q4 2024.
- In the last 5 years, Mainz Biomed's Cash & Equivalents had a median value of $8.7 million in 2021 and averaged $11.8 million.
- Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 702057.14% in 2021, then tumbled by 5875.03% in 2023.
- Over the past 5 years, Mainz Biomed's Cash & Equivalents (Quarter) stood at $8.7 million in 2021, then soared by 96.41% to $17.1 million in 2022, then tumbled by 58.75% to $7.1 million in 2023, then fell by 11.81% to $6.2 million in 2024, then changed by 0.0% to $6.2 million in 2025.
- Its Cash & Equivalents stands at $6.2 million for Q2 2025, versus $6.2 million for Q4 2024 and $7.1 million for Q2 2024.